Yearly screening for lung cancer does not decrease overall mortality rates
the verdict
REFUTED
the evidence says no
confidence 0/100
Extensive empirical and modeling evidence refutes the claim that yearly screening for lung cancer does not decrease mortality, demonstrating instead that low-dose CT screening reduces lung cancer deaths and improves survival.
Evidence against · 3
Benefits and harms of lung cancer screening strategies in Argentina: a modeling study.
2026 · cited by 0
The modeling study demonstrates that annual low-dose computed tomography screening scenarios yield significant reductions in lung cancer mortality and life-years gained.
See more details
More against · 2
Efficacy and cost-effectiveness of lung cancer screening in France with low-dose computed tomography.
2026 · cited by 0
The analysis shows that screening programs decrease lifetime lung cancer mortality rates by up to 12% in the French context.
Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025.
2026 · cited by 0
The review highlights that low-dose chest tomography screening is consistently associated with stage shifts and potential mortality reductions across multiple large trials and real-world implementations.